Barclays PLC Anika Therapeutics, Inc. Transaction History

Barclays PLC

$854 Billion
Q3 2025

A detailed history of Barclays PLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 32,074 shares of ANIK stock, worth $318,815. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,074

Previous 35,390 9.37%

Holding current value

$318,815

Previous $374,000 19.52%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$8.1 - $11.78 $26,859 - $39,062	-3,316 Reduced 9.37%	32,074 $301,000
Q2 2025 Aug 13, 2025	BUY	$10.58 - $15.05 $78,069 - $111,053	7,379 Added 26.34%	35,390 $374,000
Q1 2025 May 15, 2025	SELL	$15.03 - $17.97 $101,392 - $121,225	-6,746 Reduced 19.41%	28,011 $420,000
Q4 2024 Feb 13, 2025	BUY	$16.04 - $25.53 $33,571 - $53,434	2,093 Added 6.41%	34,757 $571,000
Q3 2024 Nov 15, 2024	BUY	$24.25 - $28.75 $316,559 - $375,302	13,054 Added 66.57%	32,664 $806,000

Q2 2024 Aug 14, 2024	SELL	$24.57 - $28.47 $202,555 - $234,706	-8,244 Reduced 29.6%	19,610 $497,000
Q1 2024 May 15, 2024	SELL	$21.95 - $26.42 $218,885 - $263,460	-9,972 Reduced 26.36%	27,854 $708,000
Q4 2023 Feb 15, 2024	BUY	$18.47 - $23.3 $204,296 - $257,721	11,061 Added 41.33%	37,826 $858,000
Q3 2023 Nov 07, 2023	BUY	$16.98 - $26.1 $37,508 - $57,654	2,209 Added 9.0%	26,765 $499,000
Q2 2023 Aug 03, 2023	BUY	$25.16 - $28.86 $100,338 - $115,093	3,988 Added 19.39%	24,556 $637,000
Q1 2023 May 04, 2023	SELL	$25.91 - $32.1 $114,133 - $141,400	-4,405 Reduced 17.64%	20,568 $591,000
Q4 2022 Feb 13, 2023	SELL	$23.85 - $31.91 $8,109 - $10,849	-340 Reduced 1.34%	24,973 $738,000
Q3 2022 Nov 03, 2022	BUY	$21.74 - $24.68 $451,561 - $512,628	20,771 Added 457.31%	25,313 $602,000
Q2 2022 Aug 12, 2022	SELL	$20.4 - $25.53 $144,942 - $181,390	-7,105 Reduced 61.0%	4,542 $101,000
Q1 2022 May 16, 2022	SELL	$24.7 - $36.54 $177,815 - $263,051	-7,199 Reduced 38.2%	11,647 $293,000
Q4 2021 Feb 14, 2022	BUY	$35.83 - $45.03 $221,895 - $278,870	6,193 Added 48.94%	18,846 $676,000
Q3 2021 Nov 09, 2021	BUY	$38.75 - $44.47 $142,096 - $163,071	3,667 Added 40.81%	12,653 $538,000
Q2 2021 Aug 13, 2021	SELL	$39.42 - $48.08 $731,280 - $891,932	-18,551 Reduced 67.37%	8,986 $389,000
Q1 2021 May 13, 2021	BUY	$32.49 - $45.96 $123,689 - $174,969	3,807 Added 16.04%	27,537 $1.12 Million
Q4 2020 Feb 11, 2021	SELL	$32.59 - $45.26 $183,970 - $255,492	-5,645 Reduced 19.22%	23,730 $1.07 Million
Q3 2020 Nov 12, 2020	BUY	$32.56 - $38.57 $159,446 - $188,877	4,897 Added 20.01%	29,375 $1.04 Million
Q2 2020 Aug 12, 2020	BUY	$27.83 - $37.73 $287,734 - $390,090	10,339 Added 73.12%	24,478 $924,000
Q1 2020 May 13, 2020	SELL	$22.38 - $54.06 $306,471 - $740,297	-13,694 Reduced 49.2%	14,139 $409,000
Q4 2019 Feb 10, 2020	SELL	$51.85 - $73.36 $380,164 - $537,875	-7,332 Reduced 20.85%	27,833 $1.44 Million
Q3 2019 Nov 14, 2019	BUY	$40.05 - $57.47 $134,808 - $193,444	3,366 Added 10.59%	35,165 $1.93 Million
Q2 2019 Aug 14, 2019	BUY	$30.3 - $41.14 $457,287 - $620,884	15,092 Added 90.33%	31,799 $1.29 Million
Q1 2019 May 15, 2019	BUY	$29.37 - $40.49 $300,043 - $413,645	10,216 Added 157.39%	16,707 $506,000
Q4 2018 Feb 14, 2019	SELL	$30.16 - $43.0 $428,754 - $611,288	-14,216 Reduced 68.65%	6,491 $219,000
Q3 2018 Nov 14, 2018	BUY	$32.83 - $42.51 $394,222 - $510,460	12,008 Added 138.04%	20,707 $872,000
Q2 2018 Aug 14, 2018	SELL	$28.77 - $48.27 $586,735 - $984,418	-20,394 Reduced 70.1%	8,699 $279,000
Q1 2018 May 15, 2018	SELL	$49.22 - $68.43 $229,906 - $319,636	-4,671 Reduced 13.83%	29,093 $1.45 Million
Q4 2017 Feb 14, 2018	BUY	$52.14 - $59.94 $233,691 - $268,651	4,482 Added 15.31%	33,764 $1.82 Million
Q3 2017 Nov 14, 2017	BUY	$51.16 - $58.21 $1.5 Million - $1.7 Million	29,282	29,282 $1.7 Million

Others Institutions Holding ANIK

# of Institutions

118

Shares Held

10.7M

Call Options Held

Put Options Held

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $145M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account